MDIT — Medite Cancer Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Medite Cancer Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2013 December 31st	R2014 December 31st	2015 December 31st	2016 December 31st	2017 December 31st
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.075	0.23	0.587	0.108	0.073
Net Total Accounts Receivable
Net Total Receivables	1.59	1.99	1.8	1.35	0.453
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6.11	5.79	5.65	5.34	3.46
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.87	2.09	1.94	1.56	1.78
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	8.17	18.6	18.4	17.8	16
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.98	6.8	6.16	7.35	3.78
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	5.55	10.2	9.21	9.75	10.2
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2.62	8.43	9.17	8.02	5.78
Total Liabilities & Shareholders' Equity	8.17	18.6	18.4	17.8	16
Total Common Shares Outstanding
Total Preferred Shares Outstanding